UVEAL MELANOMA
Clinical trials for UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive cancer drug trial halted early
Disease control TerminatedThis study tested a radioactive drug called [225Ac]-FPI-1434 in people with advanced solid tumours that had not responded to standard treatments. The goal was to find a safe dose and see if it could shrink tumours. The trial was stopped early, so results are limited. Participants…
Matched conditions: UVEAL MELANOMA
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New combo therapy for eye cancer shows promise in early trial
Disease control TerminatedThis study tested a combination of precise radiation therapy and an eye injection drug (aflibercept) for people with a rare eye cancer called uveal melanoma. The goal was to see if this approach could control the tumor while reducing damage to healthy eye tissue. Only 3 people to…
Matched conditions: UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 03:06 UTC
-
Experimental eye cancer drug trial halted early
Disease control TerminatedThis study tested a drug called BVD-523 in 13 people with advanced uveal melanoma, a rare eye cancer that had spread. The goal was to see if the drug could shrink tumors or slow the disease. The trial was stopped early, and results were limited.
Matched conditions: UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC